Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Purified Protein Derivative Response in Type 1 Diabetics

EMRE ÇELİK, YÜCEL TAŞTAN.




Abstract

Aim:
The aims of our study were to identify the role of suppressor T1 helper cells in the immunopathogenesis of type 1 diabetes mellitus (T1D) and to investigate the purified protein derivative (PPD) response, which is a delayed type of skin sensitivity response that develops secondarily to the effect of the T1 helper cell response.
Method:
Twenty-four newly diagnosed patients with T1D were included in the study (12 girls, 12 boys), and 30 (18/12) age/sex matched healthy children were included as controls. All patients underwent the PPD skin test (TST) in the first diagnostic 24–48 h (study group-1) and again 1 month after diagnosis (study group-2). The PPD response was compared with the response of healthy children. The lower limit of PPD positivity was accepted as ≥ 10 mm.
Results:
The mean PPD induration value taken in the study group-2 was statistically greater than both the study group-1 and the control group PPD (p=0.014, p=0.001). Regarding the increase in duration, the PPD positivity rate was statistically higher after the first month than in the control group (p= 0.005) and the initial PPD positivity rate (p=0.023).
Conclusion:
Interesting results emerged for the PPD response of the study group-2, because the PPD positivity rate increased over time.

Key words: Purified protein derivative (PPD), Type 1 Diabetes (T1D), Tuberculosis disease (TBC)






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.